Results 31 to 40 of about 22,848 (218)

Anaesthesia for cardioversion [PDF]

BJA Education, 2017
External direct current (DC) cardioversion refers to the application of a synchronized electrical shock across a patient’s chest using a defibrillator. The aim being to convert abnormal tachyarrhythmias back into sinus rhythm. Anaesthetists are often requested to provide anaesthesia for cardioversion because it is an extremely stimulating and painful ...
Chris Press, Patrick R. Knowles
openaire   +2 more sources

Applying DanGer Shock Eligibility Criteria to a Real‐World Cohort of Cardiogenic Shock Patients

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The DanGer Shock trial investigated the effects of adding a microaxial flow pump to guideline‐recommended therapy in patients with ST‐elevation myocardial infarction (STEMI)‐related cardiogenic shock (CS), finding a lower all‐cause mortality at 180 days in the intervention group.
Raffaela Miriam Planka, Lukas Herold, Theresa Glantschnig, Gudrun Sommer, Jonathan Pavek, Stefan Hatzl, Nicolas Verheyen, Christoph Strohhofer, Johannes Gollmer, Ewald Kolesnik, Martin Benedikt, Markus Wallner, Andreas Zirlik, Gabor Toth‐Gayor, Dirk von Lewinski   +14 more
wiley   +1 more source

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Antazoline mesylate represents an antihistamine capable of rapid and safe cardioversion of atrial fibrillation, yet evidence concerning its efficacy in comparison to other medications is insufficient.
Maciej T. Wybraniec, Wojciech Wróbel, Katarzyna Wilkosz, Karolina Wrona, Karolina Bula, Katarzyna Mizia‐Stec   +5 more
doaj   +1 more source

Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper

ESC Heart Failure, EarlyView.
The graphical abstract summarizes the key features of AFMR in terms of epidemiology, pathophysiology, diagnosis, medical therapy and rhythm control, surgical and transcatheter interventions, and future directions. Created in BioRender (https://BioRender.com/3zj03ko).
Matteo Pagnesi, Mauro Riccardi, Francesco Maisano, Julia Grapsa, Vassilis Barberis, Magdy Abdelhamid, Elena‐Laura Antohi, Henrike Arfsten, Nicole Karam, Denisa Muraru, Karl‐Philipp Rommel, Anna Sannino, Wilfried Mullens, Marianna Adamo, Marco Metra   +14 more
wiley   +1 more source

Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department

Biomedicines
Background: Atrial fibrillation (AF) is a common arrhythmia in the emergency department (ED). We investigated the role of N-terminal pro b-type natriuretic peptide (NT-proBNP) in predicting both the outcome of AF cardioversion and the risk of AF ...
Antonios Diakantonis, Christos Verras, Sofia Bezati, Vasiliki Bistola, Ioannis Ventoulis, Maria Velliou, Antonios Boultadakis, Ignatios Ikonomidis, John T. Parissis, Effie Polyzogopoulou   +9 more
doaj   +1 more source

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea

Upsala Journal of Medical Sciences, 2017
Background: Sleep apnea is common in patients with atrial fibrillation, but the effect of the cardioversion of atrial fibrillation to sinus rhythm on central and obstructive apneas is mainly unknown.
Niklas Höglund, Carin Sahlin, Milos Kesek, Steen M. Jensen, Karl A. Franklin   +4 more
doaj   +1 more source

Worsening versus advanced heart failure: Management and challenges

ESC Heart Failure, EarlyView.
Clinical feature, circulating biomarkers and therapeutic management of patients with WHF versus AdvHF. Abbreviations: AdvHF, advanced heart failure; HF, heart failure; HTx, heart transplant; GDMT, guideline‐directed medical therapy; MCS, mechanical circulatory support; NYHA, New York Heart Association; WHF, worsening heart failure.
Alberto Palazzuoli, Marco Giuseppe Del Buono, Giulia La Vecchia, Stephen J. Greene, Andrew P. Ambrosy, Ovidiu Chioncel, Finn Gustafsson, Selim R. Krim, Carl J. Lavie, Marianna Adamo, Tuvia Ben Gal, Oliviana Geavlete, Laura Antohi, Giuseppe Rosano, Sean Collins, Filippo Crea   +15 more
wiley   +1 more source

Pharmacological Therapy for Fibrillations

Journal of Arrhythmia, 2007
Human beings suffer from two different kinds of fibrillations: one is atrial fibrillation (AF) and the other is ventricular fibrillation (VF). AF is the most common sustained arrhythmia and VF is the most serious.
Akira Fujiki, MD
doaj   +1 more source

Efficiency and safety of pharmacological cardioversion for atrial fibrillation

Клинический разбор в общей медицине, 2021
Currently, atrial fibrillation is the most prevalent supraventricular tachycardia. Selection of management strategy for such patients becomes an important issue for medical practitioners.
Aleksei V. Tarasov
doaj   +1 more source

Long‐term prognosis of pure and impure tachycardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati, Michele Alfieri, Niki Tombolesi, Alessandro Barbarossa, Samuele Principi, Federico Gullì, Arianna Massari, Gianmarco Bastianoni, Francesca Roccetti, Michela Casella, Antonio Dello Russo, Federico Guerra   +11 more
wiley   +1 more source